- Filed
- Jun 10, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2026 · Jun 8, 2026 | 2.37M sh |
| Shares Diluted | FY 2026 · Mar 31, 2026 | 673.95K sh |
| Shares Diluted restated | FY 2026 · Mar 31, 2025 | 156.09K sh |
| Capex | FY 2026 · Mar 31, 2026 | $3.7K |
| Capex | FY 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | FY 2026 · Mar 31, 2026 | −$7M |
| Operating Cash Flow | FY 2026 · Mar 31, 2025 | −$7.65M |
| Cash And Equivalents | FY 2026 · Mar 31, 2026 | $5.03M |
| Cash And Equivalents | FY 2026 · Mar 31, 2025 | $5.5M |
| Stockholders Equity | FY 2026 · Mar 31, 2026 | $4.89M |
| Stockholders Equity | FY 2026 · Mar 31, 2025 | $5.12M |
| Stockholders Equity | FY 2026 · Mar 31, 2024 | $5.77M |
| Current Liabilities | FY 2026 · Mar 31, 2026 | $1.45M |
| Current Liabilities | FY 2026 · Mar 31, 2025 | $1.9M |
| Total Liabilities | FY 2026 · Mar 31, 2026 | $1.45M |
| Total Liabilities | FY 2026 · Mar 31, 2025 | $2.24M |
| Current Assets | FY 2026 · Mar 31, 2026 | $5.57M |
| Current Assets | FY 2026 · Mar 31, 2025 | $5.95M |
| Total Assets | FY 2026 · Mar 31, 2026 | $6.33M |
| Total Assets | FY 2026 · Mar 31, 2025 | $7.36M |
| Eps Diluted | FY 2026 · Mar 31, 2026 | −$10.61 |
| Eps Diluted restated | FY 2026 · Mar 31, 2025 | −$85.77 |
| Eps Basic | FY 2026 · Mar 31, 2026 | −$10.61 |
| Eps Basic restated | FY 2026 · Mar 31, 2025 | −$85.77 |
| Sga Expense | FY 2026 · Mar 31, 2026 | $2.7M |
| Sga Expense | FY 2026 · Mar 31, 2025 | $3.24M |
| Rd Expense | FY 2026 · Mar 31, 2026 | $1.91M |
| Rd Expense | FY 2026 · Mar 31, 2025 | $2.21M |
| Net Income | FY 2026 · Mar 31, 2026 | −$7.15M |
| Net Income | FY 2026 · Mar 31, 2025 | −$13.39M |
| Operating Income | FY 2026 · Mar 31, 2026 | −$7.29M |
| Operating Income | FY 2026 · Mar 31, 2025 | −$9.34M |